Mei JG - Search Results

1

Clarithromycin Synergistically Enhances Thalidomide Cytotoxicity in Myeloma Cells.

Qiu XH, Shao JJ, Mei JG, Li HQ, Cao HQ. Qiu XH, et al. Among authors: mei jg. Acta Haematol. 2016;135(2):103-9. doi: 10.1159/000438855. Epub 2015 Oct 28. Acta Haematol. 2016. PMID: 26505646

2

Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience.

Zhao Q, Li F, Song P, Zhou X, An Z, Mei J, Shao J, Li H, Wang X, Guo X, Zhai Y. Zhao Q, et al. Cancer Commun (Lond). 2019 Sep 27;39(1):51. doi: 10.1186/s40880-019-0395-3. Cancer Commun (Lond). 2019. PMID: 31558165 Free PMC article. No abstract available.

3

[Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia].

Mei JG, Li HQ, Cao HQ, Shao JJ, Zhai YP. Mei JG, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Oct;24(5):1437-1442. doi: 10.7534/j.issn.1009-2137.2016.05.028. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 27784371 Chinese.

4

Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.

Qiu XH, Li F, Cao HQ, Shao JJ, Mei JG, Li HQ, Zhai YP. Qiu XH, et al. Among authors: mei jg. Mol Med Rep. 2017 Mar;15(3):1024-1030. doi: 10.3892/mmr.2017.6140. Epub 2017 Jan 24. Mol Med Rep. 2017. PMID: 28138694 Free PMC article.

5

[Establishment and Management of Multiple Myeloma Specimen Bank Applied for Molecular Biological Researches].

Li HQ, Mei JG, Cao HQ, Shao LJ, Zhai YP. Li HQ, et al. Among authors: mei jg. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Dec;25(6):1727-1732. doi: 10.7534/j.issn.1009-2137.2017.06.027. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 29262906 Chinese.

6

[Effect and Clinical Significance of Bortezomib and Thalidomide on the Memory T Cells Subsets and Regulatory T Cells in Peripheral Blood of Patients with Multiple Myeloma].

Shi LL, Li HQ, Mei JG, Zhou XG, Li F, Song P, Zhai YP. Shi LL, et al. Among authors: mei jg. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Apr;26(2):477-483. doi: 10.7534/j.issn.1009-2137.2018.02.029. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 29665919 Chinese.

7

Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China.

Mei J, Zhai Y, Li H, Li F, Zhou X, Song P, Zhao Q, Yu Y, An Z, Wang L. Mei J, et al. J Cancer Res Clin Oncol. 2018 Nov;144(11):2263-2273. doi: 10.1007/s00432-018-2732-3. Epub 2018 Aug 24. J Cancer Res Clin Oncol. 2018. PMID: 30167888

8

Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis.

Li H, Li F, Zhou X, Mei J, Song P, An Z, Zhao Q, Guo X, Wang X, Zhai Y. Li H, et al. Ann Hematol. 2019 May;98(5):1185-1195. doi: 10.1007/s00277-019-03609-x. Epub 2019 Feb 5. Ann Hematol. 2019. PMID: 30721336 Clinical Trial.

9

[Cost-Effectiveness Analysis of Different Chemotherapy Regimens in the Treatment of Patients with Multiple Myeloma].

Lai T, Zhao Q, Li F, Zhou XG, Song P, Wang LP, Mei JG, Zhai YP. Lai T, et al. Among authors: mei jg. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):824-828. doi: 10.7534/j.issn.1009-2137.2018.03.032. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 29950227 Chinese.

10

[Relationship between the catalysis of Bence Jones protein and renal impairment in patients with multiple myeloma].

Zhou X, Zhai YP, Mei JG, An ZM, Zhou XG, Shi P, Yu YP, Liu HN, Song P. Zhou X, et al. Among authors: mei jg. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Apr;20(2):339-43. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 22541094 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters